每单位输注的较大与较小体积的红细胞在住院成人、儿童和早产儿中的应用。
Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children, and preterm neonates.
机构信息
Department of Pediatrics, Université de Montréal, Montreal, Canada.
Pediatric Intensive Care Unit, CHU Sainte-Justine, Montreal, Canada.
出版信息
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD015898. doi: 10.1002/14651858.CD015898.
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The objective of this review is to compare the effectiveness and safety of larger versus smaller RBC volume per transfusion for anemia in hospitalized adults, children, and preterm neonates.
摘要
这是一份 Cochrane 综述（干预措施）的方案。其目的如下：本次综述的目的在于比较对于住院成人、儿童和早产儿贫血患者，每单位输血中红细胞体积较大与较小的输血效果和安全性。
相似文献
1
Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children, and preterm neonates.每单位输注的较大与较小体积的红细胞在住院成人、儿童和早产儿中的应用。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD015898. doi: 10.1002/14651858.CD015898.
2
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2014 Apr 23(4):CD004868. doi: 10.1002/14651858.CD004868.pub4.
3
Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.晚期促红细胞生成素刺激剂预防早产或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2019 Feb 15;2(2):CD004868. doi: 10.1002/14651858.CD004868.pub5.
4
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD004863. doi: 10.1002/14651858.CD004863.pub3.
5
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004868. doi: 10.1002/14651858.CD004868.pub2.
6
Transfusion of red blood cells stored for shorter versus longer duration for all conditions.针对所有情况，输注储存时间较短与较长的红细胞。
Cochrane Database Syst Rev. 2018 Dec 22;12(12):CD010801. doi: 10.1002/14651858.CD010801.pub3.
7
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004863. doi: 10.1002/14651858.CD004863.pub2.
8
Early erythropoiesis-stimulating agents in preterm or low birth weight infants.早产或低出生体重婴儿早期促红细胞生成素刺激剂
Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD004863. doi: 10.1002/14651858.CD004863.pub5.
9
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2012 Sep 12(9):CD004868. doi: 10.1002/14651858.CD004868.pub3.
10
Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.晚期促红细胞生成素用于预防早产或低出生体重儿的红细胞输血。
Cochrane Database Syst Rev. 2020 Jan 28;1(1):CD004868. doi: 10.1002/14651858.CD004868.pub6.
本文引用的文献
1
Transfusion thresholds for guiding red blood cell transfusion.输血阈值指导红细胞输血。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5.
2
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
3
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.《PRISMA 2020声明：报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.
4
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2：修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
5
Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study.输血相关循环超负荷的修订国际监测病例定义：一项分类协议验证研究。
Lancet Haematol. 2019 Jul;6(7):e350-e358. doi: 10.1016/S2352-3026(19)30080-8. Epub 2019 May 9.
6
A consensus redefinition of transfusion-related acute lung injury.输血相关性急性肺损伤的共识再定义。
Transfusion. 2019 Jul;59(7):2465-2476. doi: 10.1111/trf.15311. Epub 2019 Apr 16.
7
Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.国家医疗保健安全网络血液监测模块报告的输血传播感染。
Transfus Med Rev. 2019 Apr;33(2):84-91. doi: 10.1016/j.tmrv.2019.01.001. Epub 2019 Jan 25.
8
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference.患者血液管理：2018 年法兰克福共识会议推荐意见。
JAMA. 2019 Mar 12;321(10):983-997. doi: 10.1001/jama.2019.0554.
9
Recommendations on RBC Transfusions for Critically Ill Children With Nonhemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.儿科危重病输血和贫血专业知识倡议：关于非出血性休克危重症儿童红细胞输注的建议。
Pediatr Crit Care Med. 2018 Sep;19(9S Suppl 1):S121-S126. doi: 10.1097/PCC.0000000000001620.
10
Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults.红细胞输注年龄与危重症成年患者结局的关系。
N Engl J Med. 2017 Nov 9;377(19):1858-1867. doi: 10.1056/NEJMoa1707572. Epub 2017 Sep 27.
Zotero 插件